3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
12
Prostatic Neoplasms
11
Oropharyngeal Neoplasms
10
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Glioma
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Esophageal Neoplasms
6
Neoplasm Metastasis
5
Mouth Neoplasms
5
Carcinoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Sarcoma
4
Pancreatic Neoplasms
4
Laryngeal Neoplasms
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Brain Neoplasms
4
Adenocarcinoma of Lung
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rectal Neoplasms
3
Neoplasms
3
Interventions
durvalumab
3
abemaciclib
3
Fulvestrant
3
Cisplatin
3
ribociclib
2
pembrolizumab
2
palbociclib
2
Pemetrexed
2
Nivolumab
2
Letrozole
2
Carboplatin
2
Bevacizumab
2
Anastrozole
2
130-nm albumin-bound paclitaxel
2
selpercatinib
1
selinexor
1
repotrectinib
1
relatlimab
1
relacorilant
1
olaparib
1
gallium 68 PSMA-11
1
exemestane
1
enfortumab vedotin
1
elacestrant
1
darolutamide
1
cemiplimab
1
atezolizumab
1
Tamoxifen
1
Sunitinib
1
STX-478
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
Radiation
×
90 days
×
Clear all
No trials found.